Gain Therapeutics (GANX) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Gain Therapeutics (GANX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 60K | - | - | 100K (+150.00%) | 40K (+33.33%) | 30K (+50.00%) | 20K (-75.00%) | 80K (+700.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 2.76M (+17.45%) | 2.35M (-17.54%) | 2.85M (+3.26%) | 2.76M (+22.12%) | 2.26M (+85.25%) | 1.22M (-53.44%) | 2.62M (-40.99%) | 4.44M (+76.89%) | 2.51M (+5.91%) | 2.37M (0.00%) | 2.37M (-40.60%) | 3.99M (+43.01%) | 2.79M (+22.91%) | 2.27M (+15.82%) | 1.96M (-24.03%) | 2.58M (+65.38%) | 1.56M (+6.12%) | 1.47M (-40.73%) | 2.48M (+38.55%) | 1.79M (+26.06%) | 1.42M (+44.90%) | 980K (+127.91%) | 430K (-2.27%) | 440K (+4.76%) | 420K |
Selling General And Administrative | 2.59M (+22.17%) | 2.12M (+9.28%) | 1.94M (-16.74%) | 2.33M (+10.43%) | 2.11M (0.00%) | 2.11M (+14.67%) | 1.84M (-50.93%) | 3.75M (+100.53%) | 1.87M (-7.88%) | 2.03M (-19.44%) | 2.52M (-32.62%) | 3.74M (+50.20%) | 2.49M (+8.73%) | 2.29M (-17.92%) | 2.79M (+3.72%) | 2.69M (+51.12%) | 1.78M (0.00%) | 1.78M (-18.72%) | 2.19M (+20.99%) | 1.81M (+72.38%) | 1.05M (+61.54%) | 650K (+62.50%) | 400K (+300.00%) | 100K (0.00%) | 100K |
Operating Expenses | 5.35M (+19.69%) | 4.47M (-6.68%) | 4.79M (-5.89%) | 5.09M (+16.48%) | 4.37M (+31.23%) | 3.33M (-25.34%) | 4.46M (-45.48%) | 8.18M (+86.76%) | 4.38M (-0.68%) | 4.41M (-9.82%) | 4.89M (-36.74%) | 7.73M (+46.40%) | 5.28M (+15.79%) | 4.56M (-4.00%) | 4.75M (-9.87%) | 5.27M (+58.26%) | 3.33M (+2.46%) | 3.25M (-30.26%) | 4.66M (+29.44%) | 3.60M (+45.75%) | 2.47M (+52.47%) | 1.62M (+95.18%) | 830K (+53.70%) | 540K (+3.85%) | 520K |
Depreciation And Amortization | 20K (-60.00%) | 50K (+400.00%) | 10K (0.00%) | 10K (-50.00%) | 20K (-50.00%) | 40K (+300.00%) | 10K (0.00%) | 10K (-50.00%) | 20K (-60.00%) | 50K | - | 20K (0.00%) | 20K (-50.00%) | 40K | - | 10K (0.00%) | 10K (0.00%) | 10K | - | - | - | 10K | - | - | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -5.35M (+19.69%) | -4.47M (-6.68%) | -4.79M (-5.89%) | -5.09M (+16.48%) | -4.37M (+31.23%) | -3.33M (-25.34%) | -4.46M (-45.48%) | -8.18M (+86.76%) | -4.38M (-0.68%) | -4.41M (-9.82%) | -4.89M (-36.74%) | -7.73M (+47.80%) | -5.23M (+14.69%) | -4.56M (-4.00%) | -4.75M (-8.30%) | -5.18M (+57.45%) | -3.29M (+2.49%) | -3.21M (-30.82%) | -4.64M (+32.19%) | -3.51M (+42.11%) | -2.47M (+52.47%) | -1.62M (+97.56%) | -820.00K (+54.72%) | -530.00K (+3.92%) | -510.00K |
Ebit | -5.35M (+19.69%) | -4.47M (-6.68%) | -4.79M (-5.89%) | -5.09M (+16.48%) | -4.37M (+31.23%) | -3.33M (-25.34%) | -4.46M (-45.48%) | -8.18M (+86.76%) | -4.38M (-0.68%) | -4.41M (-9.82%) | -4.89M (-36.74%) | -7.73M (+47.80%) | -5.23M (+14.69%) | -4.56M (-4.00%) | -4.75M (-8.30%) | -5.18M (+57.45%) | -3.29M (+2.49%) | -3.21M (-30.82%) | -4.64M (+32.19%) | -3.51M (+42.11%) | -2.47M (+52.47%) | -1.62M (+97.56%) | -820.00K (+54.72%) | -530.00K (+3.92%) | -510.00K |
EBITDA | -5.33M (+20.86%) | -4.41M (-7.74%) | -4.78M (-5.91%) | -5.08M (+16.78%) | -4.35M (+32.22%) | -3.29M (-26.07%) | -4.45M (-45.53%) | -8.17M (+87.39%) | -4.36M (-4.18%) | -4.55M (-3.19%) | -4.70M (-39.04%) | -7.71M (+47.98%) | -5.21M (+10.62%) | -4.71M (+3.52%) | -4.55M (-11.82%) | -5.16M (+57.32%) | -3.28M (+4.46%) | -3.14M (-32.62%) | -4.66M (+31.27%) | -3.55M (+44.31%) | -2.46M (+50.92%) | -1.63M (+106.33%) | -790.00K (+46.30%) | -540.00K (+5.88%) | -510.00K |
Net Income | |||||||||||||||||||||||||
Income Before Tax | -5.43M (+21.48%) | -4.47M (-5.70%) | -4.74M (-16.40%) | -5.67M (+27.99%) | -4.43M (+35.89%) | -3.26M (-27.07%) | -4.47M (-45.09%) | -8.14M (+104.01%) | -3.99M (-15.29%) | -4.71M (+0.21%) | -4.70M (-38.64%) | -7.66M (+49.61%) | -5.12M (+11.30%) | -4.60M (+1.10%) | -4.55M (-10.43%) | -5.08M (+55.35%) | -3.27M (+1.24%) | -3.23M (-30.69%) | -4.66M (+31.27%) | -3.55M (+44.90%) | -2.45M (+47.59%) | -1.66M (+110.13%) | -790.00K (+46.30%) | -540.00K (-6.90%) | -580.00K |
Income Tax Expense | 180K (+157.14%) | 70K (-87.27%) | 550K (+292.86%) | 140K (+40.00%) | 100K (-80.00%) | 500K (+4900.00%) | 10K | - | 20K (+100.00%) | 10K (-50.00%) | 20K (-33.33%) | 30K (+50.00%) | 20K (-75.00%) | 80K | - | 10K | - | -10.00K | 10K | - | - | - | - | - | - |
Net Income From Continuing Operations | -5.61M (+23.57%) | -4.54M (-14.02%) | -5.28M (-9.12%) | -5.81M (+28.26%) | -4.53M (+20.16%) | -3.77M (-16.04%) | -4.49M (-44.84%) | -8.14M (+102.99%) | -4.01M (-15.04%) | -4.72M (0.00%) | -4.72M (-38.62%) | -7.69M (+49.61%) | -5.14M (+10.06%) | -4.67M (+2.41%) | -4.56M (-10.41%) | -5.09M (+55.66%) | -3.27M (+1.55%) | -3.22M (-30.90%) | -4.66M (+30.90%) | -3.56M (+45.31%) | -2.45M (+47.59%) | -1.66M (+110.13%) | -790.00K (+46.30%) | -540.00K (-6.90%) | -580.00K |
Net Income | -5.61M (+23.57%) | -4.54M (-14.02%) | -5.28M (-9.12%) | -5.81M (+28.26%) | -4.53M (+20.16%) | -3.77M (-16.04%) | -4.49M (-44.84%) | -8.14M (+102.99%) | -4.01M (-15.04%) | -4.72M (0.00%) | -4.72M (-38.62%) | -7.69M (+49.61%) | -5.14M (+10.06%) | -4.67M (+2.41%) | -4.56M (-10.41%) | -5.09M (+55.66%) | -3.27M (+1.55%) | -3.22M (-30.90%) | -4.66M (+30.90%) | -3.56M (+45.31%) | -2.45M (+47.59%) | -1.66M (+110.13%) | -790.00K (+46.30%) | -540.00K (-6.90%) | -580.00K |
Comprehensive Income Net Of Tax | -5.39M (-71.84%) | -19.14M (+260.45%) | -5.31M (+3.91%) | -5.11M (+16.14%) | -4.40M (-78.96%) | -20.91M (+390.85%) | -4.26M (-47.73%) | -8.15M (+92.22%) | -4.24M (-80.78%) | -22.06M (+363.45%) | -4.76M (-37.78%) | -7.65M (+50.59%) | -5.08M (-70.90%) | -17.46M (+270.70%) | -4.71M (-8.01%) | -5.12M (+55.15%) | -3.30M (-76.14%) | -13.83M (+200.00%) | -4.61M (+29.49%) | -3.56M (+45.31%) | -2.45M (-32.88%) | -3.65M (+345.12%) | -820.00K (+51.85%) | -540.00K (-8.47%) | -590.00K |